Visa - TechWire

Visa

2025.09.02

15:43

Beilu Pharmaceutical: Haichang Pharmaceutical passed the GMP certification of the Brazilian National Health Surveillance Agency

Beilu Pharmaceutical announced that its controlling subsidiary, Haichang Pharmaceutical, recently passed the official on-site GMP certification from the Brazilian National Health Surveillance Agency (ANVISA). The certification covers the product iohexol, with the certification number 0137263/24-4. This certification lays a solid foundation for Haichang Pharmaceutical's successful entry into the Brazilian market and further expansion into other international markets, and is of positive significance to the Group's overall internationalization strategy.

2025.08.05

16:18

ST Nuotai: passed the pharmaceutical cGMP on-site inspection

ST Notech announced that it recently received its CBPF-GMP certificate, issued by the Brazilian National Health Surveillance Agency (ANVISA), a member of the PIC/S (Public Health and Medical Products Administration). This inspection covered the company's Lianyungang facility's cGMP system, which produces the APIs semaglutide and liraglutide. This on-site cGMP inspection by ANVISA marks the first time the company's semaglutide and liraglutide API production lines have passed official overseas compliance inspections, following those by the U.S. Food and Drug Administration (FDA) and the Ministry of Food and Drug Safety (MFDS) of South Korea.

2025.07.16

15:42

Bio-Thera: BAT2506 (golimumab) injection marketing authorization application accepted by the U.S. FDA

Bio-Thera announced that the company recently received a notice that the U.S. Food and Drug Administration (FDA) accepted the biologics license application (BLA) for BAT2506 (golimumab) injection. The drug is a biosimilar to golimumab, and the original drug is Simponi (Ximponi) of Johnson & Johnson, with global sales of US$2.19 billion in 2024. Bio-Thera has cooperated with many companies to carry out the commercialization process of BAT2506 (golimumab) injection in multiple regions. The drug marketing authorization application has been accepted by China NMPA, US FDA, European EMA, and Brazilian ANVISA.

2025.06.27

18:51

Rundu shares: passed the GMP certification of the Brazilian National Health Surveillance Agency

Rundu shares announced that the company accepted the on-site GMP certification of the Brazilian National Health Surveillance Agency from March 17, 2025 to March 21, 2025, and the certification scope was chemical raw materials: candesartan cilexetil, sacubitril valsartan sodium, telmisartan, and valsartan. Recently, the company received two GMP certification certificates issued by Brazil's ANVISA, which are valid until May 26, 2027 and June 9, 2027. The conclusion of the on-site inspection by Brazil's ANVISA is qualified, that is, the company's four raw material products have passed the Brazilian ANVISA on-site GMP certification.

2025.04.30

04:20

VISA's second-quarter net revenue of $9.59 billion is higher than market expectations

VISA's second-quarter net revenue was $9.59 billion, compared with an estimated $9.55 billion; second-quarter adjusted earnings per share were $2.76, compared with an estimated $2.68.

2025.02.21

00:36

VISA CEO: Stablecoin transaction volume has increased by 40% in the past two years.

2025.01.28

23:01

CEO of social media platform "X": XMONEY accounts will be launched later this year, and VISA is the first partner.

2024.12.19

12:35

JEFFERIES: Raise Visa price target from $360 to $370

JEFFERIES: Raise VISA price target from $360 to $370.

2024.10.30

02:57

Visa plans to lay off about 1,400 employees and contractors, report says

Asia Tech Wire (Oct 30) -- Visa Inc. plans to lay off about 1,400 employees and contractors by the end of this year, as part of a plan to streamline its international operations, according to a Wall Street Journal report citing people familiar with the matter.

2024.09.24

02:39

U.S. DOJ said to accuse Visa of alleged illegal monopolization of debit card market

Asia Tech Wire (Sep 24) -- The U.S. Department of Justice plans to charge Visa with allegedly illegally monopolizing the U.S. debit card market, Bloomberg said, citing people familiar with the matter.

2024.07.17

06:10

Japan conducts on-site inspection of Visa over alleged antitrust violations

Asia Tech Wire (July 17) -- The Japan Fair Trade Commissionon (JFTC) Wednesday conducted an on-site inspection of Visa Inc.'s subsidiary in Japan over alleged antitrust violations.

2024.05.24

07:19

Visa to launch new products, services in Asia Pacific for digital age

Asia Tech Wire (May 24) -- Visa Inc. announced this week that it plans to launch a range of new products and services for the digital age in the Asia Pacific region in the second half of this year.

2022.02.17

05:57

Amazon reaches agreement with Visa over payment fees

Asian Tech Press (Feb 17) -- Amazon.com Inc reportedly reached an agreement with Visa Inc. on the fees for using Visa cards for payments on its website.

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    China Great Wall: The company's AI server power supply has officially started production
                            2025-10-27

                                    Most Chinese stocks in the US stock market rose before the market opened, with Baidu rising 4%.
                            2025-10-27

                                    Meituan's video generation model is officially released and open sourced
                            2025-10-27

                                    Gree and JD.com's sales volume is expected to exceed 20 billion yuan this year
                            2025-10-27

                                    Koss Technology: Net profit loss of 79.2849 million yuan in the third quarter
                            2025-10-27